Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens: Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment

Journal of Investigational Allergology and Clinical Immunology

Volumn 13, Issue 2, 2003, Pages 108-117

  Guerra, Francisco ^a   Daza, J C ^a   Almeda, E ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Allergen vaccine; Bronchial provocation; Clinical efficacy; Immunotherapy; Olea europaea

Indexed keywords

ANTIHISTAMINIC AGENT; BUDESONIDE; CORTICOSTEROID; GLUTARALDEHYDE; POLLEN ANTIGEN; POLLEN EXTRACT; SALBUTAMOL; VACCINE;

ALLERGIC ASTHMA; ANALYSIS OF VARIANCE; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOOD CLINICAL PRACTICE; HUMAN; IMMUNOTHERAPY; KRUSKAL WALLIS TEST; OLEACEAE; OLIVE TREE; POLLEN ALLERGY; POLYMERIZATION; PRICK TEST; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

ALLERGENS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; DESENSITIZATION, IMMUNOLOGIC; HUMANS; OLEA; POLLEN; RESPIRATORY HYPERSENSITIVITY; SAFETY; SKIN TESTS; TREATMENT OUTCOME; VACCINES;

EID: 0042510918     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Grammer, L.C., Shaughnessy, M.A., Shaughnessy, J.J., Patterson, R. Safety and immunogenicity of immunotherapy with accelerated dosage schedules of polymerized grass and ragweed in patients with dual inhalant sensitivity. J Allergy Clin Immunol 1989, 83(4):750-756.
2. Grammer, L.C., Shaughnessy, M.A., Suszko, I.M., Shaughnessy, J.J., Patterson, R. A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. J Allergy Clin Immunol 1983, 72(5 Pt 1):448-453.
3. Grammer, L.C., Shaughnessy, M.A., Finkle, S.M., Shaughnessy, J.J., Patterson, R. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis. J Allergy Clin Immunol 1986, 78(6):1180-1184.
4. Grammer, L.C., Shaughnessy, M.A., Patterson, R. Modified forms of allergen immunotherapy. J Allergy Clin Immunol 1985, 76(2 Pt 2):397-401.
5. Bousquet, J., Michel, F.B. Safety considerations in assessing the role of immunotherapy in allergic disorders. Drug Saf 1994, 10(1):5-17.
6. Berrens, L., Gallego, M.T., Boluda, L., Fernández-Caldas, E., González, L. Complexed flavonoids on pollen protein allergens revealed by uv-spectroscopy and thin-layer chromatography. Allergy 1998, 53(suppl):56.
7. Liccardi, G., D'Amato, M., D'Amato, G. Oleaceae pollinosis: a review. Int Arch Allergy Immunol 1996, 111(3):210-217.
8. Guerra, F., Moreno, C., Daza, J.C., Miguel, R., Garcia, M., Sanchez Guijo, P. Linear monitoring of patients sensitive to Olea and grass pollens treated with immunotherapy based on glutaraldehyde-modified (allergoid) extracts. J Invest Allergol Clin Immunol 1993, 3(4):182-190.
9. Nordic Council on Medicines. Registration of allergen preparations. Nordic-guidelines. Prepared by the Nordic Council on Medicines in cooperation with the Drug Regulatory Authorities in Denmark, Finland, Iceland, Norway and Sweden. NLN Publication No. 23 1989; Edn. January (Chapter 5, Clinical Documentation), p. 21.
10. Bousquet, J., Lockey, R., Malling, H.J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. Allergy 1998, 53(suppl):1-42.
11. EAACI. Position paper: Allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy 1993, 48(14 suppl):48-82.
12. Nordic Council on Medicines. Registration of allergen preparations. Nordic-guidelines. Prepared by the Nordic Council on Medicines in cooperation with the Drug Regulatory Authorities in Denmark, Finland, Iceland, Norway and Sweden. NLN Publication No. 23 1989; Edn. January (Chapter 5, Clinical Documentation), p. 25-34.
13. Cockcroft, D.W., Killian, D.N., Mellon, J.J., Hargreave, F.E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977, 7(3):235-243.
14. Frolund, L. Bronchial allergen challenge methodological studies. Allergy 1996, 51(29 suppl):1-41.
15. Fish, J.E., Ankin, M.G., Adkinson, N.F., Peterman, V.I. Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma. Am Rev Respir Dis 1981, 123(6):609-614.
16. Ruffin, R.E., Cockcroft, D.W., Hargreave, F.E. A comparison of the protective effect of fenoterol and Sch 1000 on allergen-induced asthma. J Allergy Clin Immunol 1978, 61(1):42-47.
17. Kopferschmitt-Kubler, M.C., Bigot, H., Pauli, G. Allergen bronchial challenge tests: variability and reproducibility of the early response. J Allergy Clin Immunol 1987, 80(5):730-740.
18. Galan, C., Infante, F., Ruiz de Clavijo, E., Guerra, F., Miguel, R., Dominguez, E. Allergy to pollen grains from Amaranthaceae and Chenopodiaceae in Cordoba, Spain. Annual and daily variation of pollen concentration. Ann Allergy 1989, 63(5):435-438.
19. Feo Brito, F., Martínez, C., Gómez, E., Galindo, P.A., Borja, J., Mur, P. Nuevos aspectos de la aerobiología de los pólenes. Oleáceas. In C. Colás, J. Fraj, A. Lezaun (Eds.), Alergoaragón. Debates sobre Alergología. Formigal, Febrero 2000, p. 35-41. Dep. Legal B-363112-2000.
20. Dreborg, S., Agrell, B., Foucard, T., Kjellman, N.I., Koivikko, A., Nilsson, S. Adouble-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986, 41(2):131-140.
21. Patterson, R., Suszko, I.M., Pruzansky, J.J., Zeiss, C.R. Polymerized ragweed antigen e. II. in vivo elimination studies and reactivity with IgE antibody systems. J Immunol 1973, 110(5):1413-1418.
22. Patterson, R., Suszko, I.M., McIntire, F.C. Polymerized ragweed antigen E. I. Preparation and immunologic studies. J Immunol 1973, 110(5):1402-1412.
23. Sachs, D.H., Winn, H.J. The use of glutaraldehyde as a coupling agent for ribonuclease and bovine serum albumin. Immunochemistry 1970, 7(6):581-585.
24. Boluda, L., Sastre, J., Casanovas, M., Fernandez-Caldas, E. Determination of Ole e 1 by enzyme immunoassay and scanning densitometry. Validation by skin-prick testing. J Immunol Methods 1999, 223(1):17-26.
25. Pharmacopeia E. Allergen Products (1997:1063). In. Third edition ed; 1997.
26. Casanovas, M., Maranon, F., Bel, I. Comparison of skin-prick test assay and reverse enzyme immunoassay competition (REINA-C) for biological activity of allergens. Clin Exp Allergy 1994, 24(2):134-139.
27. Boluda, L., Gallego, M.T., Gonzalez-Romano, M.L., Cambra, O., Berrens, L. Evaluation of the potency of allergenic extracts by inhibition of IgG-antibody binding. Biologicals 1994, 22(2):171-177.
28. Immunotherapy Subcommittee E. Position paper: Immunotherapy. (EAACI) The European Academy of Allergology and Clinical Immunology. Allergy 1993, 48(14 suppl):7-35.
29. Bousquet, J., Hejjaoui, A., Soussana, M., Michel, F.B. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990, 85(2):490-497.
30. Finney, D.J. Statistical methods in biological assay. New York: Hafner 1964.
31. Glanz, S.A., Slinker, B.K. The first step: understanding simple linear regression. In S.A. Glanz, B.K. Slinker (Eds.), Primer of applied regression and analysis of variance. New York: McGraw-Hill 1990, p. 27-35.
32. Bodtger, U., Poulsen, L.K., Jacobi, H.H., Malling, H.J. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Allergy 2002, 57(4):297-305.
33. Walker, S.M., Pajno, G.B., Lima, M.T., Wilson, D.R., Durham, S.R. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001, 107(1):87-93.
34. Bolton, S. Comparison of slopes and testing for linearity: Determination of the relative potency. In S. Bolton (Ed.), Pharmaceutical statistics. New York: Marcel Decker 1990, p. 575-582.
35. Cropp, G.J. Relative sensitivity of different pulmonary function tests in the evaluation of exercise-induced asthma. Pediatrics 1975, 56(5 pt-2 suppl):860-867.
36. Fish, J.E., Kelly, J.F. Measurements of responsiveness in bronchoprovocation testing. J Allergy Clin Immunol 1979, 64(6 pt 2):592-596.
37. Kopferschmitt-Kubler, M.C., Bigot, H., Pauli, G. Allergen bronchial challenge tests: variability and reproducibility of the early response. J Allergy Clin Immunol 1987, 80(5):730-740.
38. Spector, S., Luparello, T.J., Kopetzky, M.T., Souhrada, J., Kinsman, R.A. Response of asthmatics to methacholine and suggestion. Am Rev Respir Dis 1976, 113(1):43-50.
39. Yang, X. Does allergen immunotherapy alter the natural course of allergic disorders? Drugs 2001, 61(3):365-374.
40. World Health Organization. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998, 53 (Suppl):1-42.
41. Bacal, E., Zeiss, C.R., Suszko, I., Levitz, D., Patterson, R. Polymerized whole ragweed: an improved method of immunotherapy. J Allergy Clin Immunol 1978, 62(5):288-294.
42. Moran, D.M., Wheeler, A.W. Chemical modification of crude timothy grass pollen extract. I. Antigenicity and immunogenicity changes following amino group modification. Int Arch Allergy Appl Immunol 1976, 50(6):693-708.
43. Wheeler, A.W., Drachenberg, K.J. New routes and formulations for allergen-specific immunotherapy. Allergy 1997, 52(6):602-612.
44. Gieni, R.S., Yang, X., Kelso, A., Hayglass, K.T. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Immunology 1996, 87(1):119-126.
45. Hayglass, K.T., Stefura, W.P. Antigen-specific inhibition of ongoing murine IgE responses. II. Inhibition of IgE responses induced by treatment with glutaraldehyde-modified allergens is paralleled by reciprocal increases in IgG2a synthesis. J Immunol 1991, 147(8):2455-2460.
46. Yang, X., Gieni, R.S., Mosmann, T.R., Hay-Glass, K.T. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med 1993, 178(1):349-353.